Cyclooxygenase-2 and colorectal cancer.
DuBois
Raymond N
RN
Department of Medicine and Cell Biology, Vanderbilt University Medical Center, Department of Veterans Affairs Medical Center, Nashville, Tenn., USA. raymond.dubois@mcmail.vanderbilt.edu
D011125:Adenomatous Polyposis Coli / Q000188:drug therapy; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003111:Colonic Polyps / Q000517:prevention & control; D015179:Colorectal Neoplasms / Q000209:etiology / Q000517:prevention & control*; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors* / Q000502:physiology; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases / Q000502:physiology; D011982:Receptors, Prostaglandin / Q000502:physiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D011982:Receptors, Prostaglandin; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases